OMRF has discovered a targeted therapy that could improve treatment and long-term outcomes for ovarian cancer.
Stephenson Cancer Center
OMRF discoveries reshape understanding of gut microbiome
OMRF scientists have redefined how the gut microbiome operates and how our bodies coexist with some of the 100 trillion bacteria that make it up.
OMRF holds first meeting of Nonagenarian Society
The Nonagenarian Society was created by longtime OMRF board member H.E. “Gene” Rainbolt.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?
As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
